AASLD/AST/NASPGHAN实践指南:儿童肝移植术后管理
该指南由美国肝病研究学会(AASLD)联合北美小儿胃肠病、肝病与营养学会(NASPGHAN)及美国移植学会(AST)制定,针对儿童肝移植受者的术后综合管理。写作组进行系统性全球文献回顾,提出关键临床问题并形成推荐,采用牛津循证医学中心框架对每条推荐进行分级,并通过共识投票确定推荐强度。指南聚焦于在保护移植肝与减轻治疗负担之间取得平衡,涵盖减少并发症的手术与重症监护策略、免疫抑制暴露最小化、感染预防(预防用药与疫苗接种)、早期营养与发育支持优化,以及从儿科向成人医疗过渡的支持。结论指出,多数证据仍为回顾性、观察性数据或来自相关人群的外推,未来需多学科、多中心协作以强化证据。
要点
- 指南推荐对儿童肝移植受者进行综合管理,核心是在保护移植肝与减轻治疗总体负担之间取得平衡。
- 管理重点包括减少免疫抑制暴露及其对其他器官的长期不良影响,并通过预防用药和疫苗接种预防感染。
- 需优化早期营养与发育支持,并改善从儿科向成人医疗过渡期的支持。
- 推荐基于牛津循证医学中心框架分级,并经共识投票确定推荐强度。
- 多数证据为回顾性、观察性数据或相关人群外推,需多学科、多中心协作强化证据。
适用人群与场景
- 儿童肝移植受者,从移植开始并持续至成年期的综合管理。
处置流程与药物剂量
- 减少并发症的手术与重症监护策略。
- 最小化免疫抑制暴露及其对其他器官的长期不良影响。
- 通过预防用药和疫苗接种预防感染。
- 优化早期营养与发育支持。
- 改善从儿科向成人医疗过渡期的支持。
研究设计与关键结果
- 制定机构:美国肝病研究学会(AASLD),与北美小儿胃肠病、肝病与营养学会(NASPGHAN)及美国移植学会(AST)合作。
- 方法:多学科写作组进行系统性全球文献回顾,提出关键临床问题并形成推荐;每条推荐采用牛津循证医学中心框架分级,并通过共识投票确定推荐强度。
证据类型、等级与局限
- 证据类型:指南;推荐采用牛津循证医学中心框架分级,并经共识投票确定推荐强度。
- 局限:多数证据为回顾性、观察性数据或来自相关人群的外推;需多学科、多中心协作以强化证据。
对床旁实践的改变
- 指南强调在儿童肝移植术后管理中平衡保护移植肝与减轻治疗总体负担,具体做法包括减少免疫抑制暴露、预防感染、优化营养与发育支持及完善过渡期支持。
指南或共识出处
- AASLD/AST/NASPGHAN实践指南:儿童肝移植术后管理(AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Posttransplant management)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND AIM: Optimizing health and quality of life for pediatric recipients of liver transplant (LT) requires balancing the protection of the liver graft with the overall burden of treatments on the child. Since the American Association for the Study of Liver Diseases (AASLD)'s 2013 guidelines, strategies for achieving this balance have evolved, with a particular focus on mitigating long-term complications. Advances include operative and intensive care strategies for reducing complications, minimizing exposure to immunosuppression and its long-term adverse effects on other organs, infection prevention with prophylaxis and vaccination, optimizing support of early nutrition and development, and improving support around transition from pediatric to adult care. This document aims to provide an evidence-based guideline for the comprehensive care of pediatric recipients of LT, starting at transplant and continuing as they advance to adulthood.
METHODS: A multidisciplinary writing group of pediatric LT experts and a medical librarian was convened by AASLD, with guidance by its Practice Guidelines Development Policy, and in collaboration with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Society of Transplantation (AST). We conducted a systematic global literature review, formulated key clinical questions, and developed recommendations. Each recommendation was graded using the Oxford Centre for Evidence-Based Medicine framework and categorized by strength through a consensus voting process.
CONCLUSION: All recommendations are based on the best available evidence and reflect expert consensus. Most of the evidence base remains retrospective or observational data, or extrapolation from related populations. To continue improving long-term outcomes after pediatric LT, multidisciplinary, multicenter collaboration to strengthen the evidence will be essential.
参考来源
- Perito ER, Chen JK, Danziger-Isakov LA, et al. AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Posttransplant management. Liver Transpl. 2026. PMID: 42329162. doi:10.1097/LVT.0000000000000939
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。